Powered by: Motilal Oswal
2025-09-24 11:41:37 am | Source: Accord Fintech
Poly Medicure rises on acquiring 90% stake in PendraCare group
Poly Medicure rises on acquiring 90% stake in PendraCare group

Poly Medicure is currently trading at Rs. 1966.80, up by 16.80 points or 0.86% from its previous closing of Rs. 1950.00 on the BSE.

The scrip opened at Rs. 1968.95 and has touched a high and low of Rs. 1985.50 and Rs. 1942.40 respectively. So far 2977 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3350.00 on 01-Nov-2024 and a 52 week low of Rs. 1822.65 on 13-Aug-2025.

Last one week high and low of the scrip stood at Rs. 2109.90 and Rs. 1933.00 respectively. The current market cap of the company is Rs. 19900.88 crore.

The promoters holding in the company stood at 62.44%, while Institutions and Non-Institutions held 23.13% and 14.44% respectively.

Poly Medicure’s wholly owned step-down subsidiary -- RisoR Holdings B.V., Amsterdam, Netherlands has signed a share purchase agreement with Wellinq Holdings B.V. Amsterdam, Netherlands, for the purpose of acquisition of ordinary shares of Pendracare Holdings B.V. and Wellinq Medical B.V. (PendraCare Group). The company through Risor Holding B.V. owns 90% stake in the PendraCare group. Subsequently, Wellinq Medical B.V. and PendraCare Holding B.V. have become the step-down subsidiaries of the company. 

Earlier, the company had signed definitive agreements to acquire 90% stake in PendraCare Group consisting of PendraCare Holdings and Wellinq Medical from Wellinq Holdings B.V. at an Enterprise value of 18.3 million euros.

Poly Medicure is one of the leading Medical Devices company and exporter in India.

 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here